CDK4 and cancer: All together, these findings indicate that high expression of CDK4 strongly correlates with cancer stem cell-enriched subtype of breast cancer, specifically the triple-negative group and that the CDK4 kinase activity is required for maintaining the subpopulation of CD44high/CD24neg BCSC.